The global CD147 antibody market is booming, reaching $150 million in 2025 and projected to grow at an 8% CAGR through 2033. Driven by advancements in cancer and infectious disease research, this report analyzes market trends, key players (BosterBio, Abcam, etc.), and regional growth, offering valuable insights for investors and industry professionals. Explore the potential of monoclonal vs. polyclonal antibodies and diverse applications like IHC and immunofluorescence.

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.